Connect with us

Cannabis

Why Colombia’s Cannabis Genetics Exports Are Growing

Colombia’s cannabis genetics exports are growing, with in vitro plants favored for their phytosanitary quality and stability. The ICA has inspected over 6,000 units for shipment to Asia and Europe. In 2025, Colombia exported to Israel for the first time, expanding to the UK, Switzerland, and the EU, boosting its global leadership in cannabis genetics.

Published

on

cannabis

In recent years, international demand for Colombian cannabis genetics has grown significantly, positioning in vitro plants as a preferred export method due to their phytosanitary quality and genetic stability. Over the past five years, the Colombian Agricultural Institute (ICA) has inspected 6,075 units of cannabis planting material destined for various countries in Asia and Europe.

Colombian cannabis exporters are able to maintain access to international markets

The ICA has played a critical role in this export process through its inspection points at airports, ports, and border crossings across the country. These inspections ensure that all cannabis planting materials meet the phytosanitary and regulatory requirements established by destination countries. As a result, Colombian cannabis exporters are able to maintain access to international markets, with the cannabis planting materials recognized for their high standards and efficiency.

A significant milestone occurred in 2025, when 60 units of in vitro cannabis material were exported to Israel for the first time. This shipment was carried out by Richmond Seeds, with support from Medellín Labs. This marks an important step in Colombia’s cannabis export trajectory, as it demonstrates the increasing acceptance and demand for Colombian in vitro cannabis genetics in new, highly regulated markets.

The ICA continues to facilitate these exports, extending their reach to destinations such as the United Kingdom, Switzerland, and the European Union. This work strengthens the presence of Colombian cannabis genetics in markets that demand high-quality, scientifically developed planting materials.

These efforts reflect an ongoing collaboration between the ICA and companies within the cannabis sector to promote Colombia as a global leader in cannabis genetics. The use of in vitro methods not only supports phytosanitary compliance but also contributes to the scientific development of more resilient and efficient plants. Together, the ICA and the private sector are driving Colombia’s position in international markets by focusing on innovation, quality assurance, and regulatory compliance.

__

(Featured image by Elsa Olofsson via Pexels)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in AGRONEGOCIOS. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Arturo Garcia started out as a political writer for a local newspaper in Peru, before covering big-league sports for national broadsheets. Eventually he began writing about innovative tech and business trends, which let him travel all over North and South America. Currently he is exploring the world of Bitcoin and cannabis, two hot commodities which he believes are poised to change history.